カタログ製品コード : C-EK12172
Human CD258/LIGHT/TNFSF14 ELISA kit
| 24T | ¥55,200 | (¥2,300/T) (税別) |
| 48T | ¥69,200 | (¥1,442/T) (税別) |
| 96T | ¥78,000 | (¥813/T) (税別) |
標準納期 : 2週間 |
製品詳細
| メーカー名 | 遺伝子名 | 種交差性 | 測定範囲 | サンプル量 | 適用サンプル | ドキュメント |
|---|---|---|---|---|---|---|
| MultiSciences | CD258/LIGHT/TNFSF14 | Human | 312.50 - 20000 pg/ml | 20 μl | 血清、血漿、細胞培養上清 |
|
■保存方法 :
キットは未開封の場合、4℃で保管すること。 開封後は標準溶液を-20℃で保存し、他の試薬は4℃で保存すること。
■構成内容 :
| 96-well polystyrene microplate coated with a monoclonal antibody against CD258 |
| Human CD258 Standard, lyophilized |
| CD258 Detect Antibody |
| Standard Diluent |
| Streptavidin-HRP |
| Assay Buffer (10×) |
| Substrate (TMB) |
| Stop Solution |
| Washing Buffer (20×) |
| Plate Covers |
■キーワード :
Homo sapiens,Human,Tumor necrosis factor ligand superfamily member 14,Herpes virus entry mediator ligand,HVEM-L,Herpesvirus entry mediator ligand,TNFSF14,HVEML,LIGHT,UNQ391/PRO726,CD258
■ターゲット情報 :
This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human CD258. The HumanCD258/LIGHT/TNFSF14 ELISA is for research use only. Not for diagnostic or therapeutic procedures.
CD258, also known as LIGHT and tumor necrosis factor superfamily member 14 (TNFSF14), is a secreted protein of the TNF superfamily. It is a type II transmembrane protein expressed on activated T cells and immature dendritic cells and recognized by herpesvirus entry mediator (HVEM), as well as decoy receptor 3. This protein may function as a costimulatory factor for the activation of lymphoid cells and as a deterrent to infection by herpesvirus. This protein has been shown to stimulate the proliferation of T cells, trigger apoptosis of various tumor cells and block viral entry. It is also reported to prevent TNF alpha mediated apoptosis in primary hepatocyte. In addition, CD258 has been implicated in T cell development and homeostasis, dendritic cell maturation, and atherogenesis and may play a prominent role in diseases involving T cells such as graft versus host disease (GVHD) and autoimmune conditions.
